# Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab

> **NCT01402544** · PHASE2,PHASE3 · TERMINATED · sponsor: **University of California, San Diego** · enrollment: 20 (actual)

## Conditions studied

- Age-Related Macular Degeneration

## Interventions

- **DRUG:** ranibizumab

## Key facts

- **NCT ID:** NCT01402544
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-07
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** Per study sponsor decision.
- **Last updated:** 2019-08-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01402544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01402544, "Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01402544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*